Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial.
Haque T, Wilkie GM, Jones MM, Higgins CD, Urquhart G, Wingate P, Burns D, McAulay K, Turner M, Bellamy C, Amlot PL, Kelly D, MacGilchrist A, Gandhi MK, Swerdlow AJ, Crawford DH.
Haque T, et al.
Blood. 2007 Aug 15;110(4):1123-31. doi: 10.1182/blood-2006-12-063008. Epub 2007 Apr 27.
Blood. 2007.
PMID: 17468341
Free article.
Clinical Trial.